| Related Information: |
| European Union: Nitrosamines: EMA aligns recommendations for sartans with those ... Posted 2020-11-14 |
| The United States: FDA updates and press announcements on angiotensin II recepto... Posted 2019-11-14 |
| The United States: Torrent Pharmaceuticals Limited expands voluntary nationwide ... Posted 2019-09-21 |
| United States: Macleods Pharmaceutical Limited Issues Voluntary Nationwide Consu... Posted 2019-06-27 |
| The United States: Teva Pharmaceuticals USA, Inc. expands voluntary nationwide r... Posted 2019-06-12 |
| The United States: Sciegen Pharmaceuticals, Inc. issues voluntary nationwide rec... Posted 2019-06-12 |
| Singapore: Recall of three brands of losartan products found to contain N-Nitros... Posted 2019-05-09 |
| The United States: Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Rec... Posted 2019-05-04 |
| The United States: Teva Pharmaceuticals USA, Inc. issues voluntary nationwide re... Posted 2019-04-29 |
| The United States: Legacy Pharmaceutical Packaging, LLC expands voluntary nation... Posted 2019-04-25 |
| Canada: Auro Pharma Inc. voluntarily recalls one lot of Auro-Irbesartan HCT tabl... Posted 2019-04-23 |
| The United States: Updated: Torrent Pharmaceuticals Limited expands voluntary na... Posted 2019-04-23 |
| Singapore: HSA recalls three brands of losartan medicines from Hetero Labs Ltd Posted 2019-03-29 |
| 台灣：回收緩壓膜衣錠 50 毫克 Losacar 50 Tablets (Chinese Only) Posted 2019-03-23 |
| 台灣：回收壓寧悅膜衣錠 50/12.5 毫克 Hysartan F.C. Tablets 50/12.5 mg (Chinese Only) Posted 2019-03-23 |
| The United Kingdom: Class 2 Medicines recall: Accord Healthcare Limited - Losart... Posted 2019-03-22 |
| The United States: Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationw... Posted 2019-03-16 |
| Canada: Pro Doc Limitée voluntarily recalls two lots of irbesartan drugs because... Posted 2019-03-15 |
| Canada: Multiple losartan-containing drugs voluntarily recalled because of poten... Posted 2019-03-11 |
| The United States: American Health Packaging issues voluntary nationwide recall ... Posted 2019-03-08 |
| 台灣：Sartan類高血壓又發現新的不純物NMBA，食藥署啟動預防性下架機制 (Chinese Only) Posted 2019-03-04 |
| The United States: Updated: Torrent Pharmaceuticals Limited issues voluntary nat... Posted 2019-03-02 |
| The United States: Aurobindo Pharma USA, Inc. initiates a voluntary nationwide c... Posted 2019-03-02 |
| The United States: Camber Pharmaceuticals, Inc. issues voluntary nationwide reca... Posted 2019-03-01 |
| 台灣：食藥署說明沙坦類（sartan）藥品中「N-亞硝基二甲胺（NDMA）」及「N-亞硝基二乙胺（NDEA）」之處理現況 (Chinese Only) Posted 2019-02-28 |
| The United States: Macleods Pharmaceuticals Limited issues voluntary nationwide ... Posted 2019-02-26 |
| Australia: ‘Sartan’ blood pressure medicines: TGA investigation - potential cont... Posted 2019-02-26 |
| 台灣：有關健喬信元醫藥生技股份有限公司「衛欣保膜衣錠80毫克」、「衛欣保膜衣錠160毫克」及景德製藥股份有限公司「"景德"定壓寧膠囊80毫克」回收事件說明 (C... Posted 2019-02-16 |
| The United Kingdom: Class 2 Medicines Recall: Actavis Group PTC EHF - Irbesartan... Posted 2019-02-14 |
| European Medicines Agency: Press release: Sartan medicines: companies to review ... Posted 2019-02-02 |
| The United Kingdom: Class 2 Medicines Recall: Macleods Pharma UK Limited - Irbes... Posted 2019-01-25 |
| The United States: Torrent Pharmaceuticals Limited issues voluntary nationwide r... Posted 2019-01-23 |
| 台灣：食藥署說明目前完成清查沙坦類（Sartan）藥品中「N-亞硝基二甲胺（NDMA）」及「N-亞硝基二乙胺（NDEA）」之檢驗結果 (Chinese Only... Posted 2019-01-21 |
| The United States: Prinston Pharmaceutical Inc. issues voluntary nationwide reca... Posted 2019-01-19 |
| The United Kingdom: Class 2 Medicines Recall: Actavis Group PTC EHF - recall of ... Posted 2019-01-04 |
| The United States: Aurobindo Pharma USA, Inc. initiates voluntary nationwide con... Posted 2019-01-02 |
| 台灣: 有關壽元化學工業股份有限公司回收「脈莎平膜衣錠 50 毫克」事件說明 (Chinese Only) Posted 2018-12-31 |
| 台灣: 回收脈莎平膜衣錠 50 毫克 Cosar F.C. Tablets 50 mg (Chinese Only) Posted 2018-12-28 |
| Canada: Health Canada releases test results of certain sartan drugs Posted 2018-12-21 |
| The United States: Torrent Pharmaceuticals Limited issues voluntary nationwide r... Posted 2018-12-21 |
| Australia: Recall for IRBESARTAN／HCT SANDOZ 300／12.5 and IRBESARTAN／HCT SANDOZ 3... Posted 2018-12-19 |
| Australia: Recall - potential contamination: APO-Valsartan (valsartan) tablets Posted 2018-12-19 |
| The United States: FDA warns API manufacturer involved in valsartan recall, prov... Posted 2018-12-12 |
| The United States: Mylan expands its voluntary nationwide recall of Valsartan Ta... Posted 2018-12-05 |
| The United Kingdom: Class 2 Medicines Recall: Teva UK Limited and Mylan - recall... Posted 2018-12-01 |
| Canada: Information Update - Mylan-Valsartan medications voluntarily recalled as... Posted 2018-11-30 |
| The United States: Teva Pharmaceuticals USA issues voluntary nationwide recall o... Posted 2018-11-28 |
| Australia: Recall - potential contamination: Dilart and Dilart HCT (valsartan) Posted 2018-11-23 |
| 台灣：回收洛沙坦山德士膜衣錠50/12.5毫克 Losartan Sandoz Comp Film Coated Tablet 50/12.5 mg (Chin... Posted 2018-11-23 |
| The United States: Mylan initiates voluntary nationwide recall of 15 lots of Val... Posted 2018-11-22 |
| 台灣：有關健亞生物科技股份有限公司回收「壓穩膜衣錠80毫克」及「壓穩膜衣錠160毫克」事件說明 (Chinese Only) Posted 2018-11-21 |
| 台灣：回收壓穩膜衣錠80毫克 Prevan Film-Coated Tablets 80mg (Chinese Only) Posted 2018-11-20 |
| European Union: Valsartan from Mylan laboratories in India can no longer be used... Posted 2018-11-20 |
| 台灣：回收壓穩膜衣錠160毫克 Prevan Film-coated Tablets 160mg (Chinese Only) Posted 2018-11-20 |
| The United States: Sandoz Inc. issues voluntary nationwide recall of one lot of ... Posted 2018-11-10 |
| 台灣：食藥署調查使用印度Aurobindo Pharma Limited公司Irbesartan原料藥之異常事件說明，及回收「平壓妥膜衣錠300毫克Bestan... Posted 2018-11-03 |
| The United States: ScieGen Pharmaceuticals, Inc. issues voluntary nationwide rec... Posted 2018-10-31 |
| The United States: Aurobindo Pharma Limited issues voluntary recall of irbesarta... Posted 2018-10-30 |
| The United States: FDA updates recalled valsartan-containing product information Posted 2018-10-25 |
| European Union: EU authorities take further action in ongoing review of sartans:... Posted 2018-10-16 |
| The United States: FDA posts laboratory analysis of NDMA levels in recalled vals... Posted 2018-10-06 |
| Canada: Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant w... Posted 2018-10-03 |
| The United States: FDA places Zhejiang Huahai Pharmaceuticals on import alert Posted 2018-10-02 |
| European Union: EU inspection finds Zhejiang Huahai site non-compliant for manuf... Posted 2018-09-29 |
| European Union: Valsartan: review of impurities extended to other sartan medicin... Posted 2018-09-22 |
| European Union: Update on review of valsartan medicines. Risk from NDMA remains ... Posted 2018-09-14 |
| The United States: FDA provides update on its ongoing investigation into valsart... Posted 2018-09-14 |
| Canada: Health Canada advises of a second impurity linked to recalled valsartan ... Posted 2018-09-14 |
| Canada: Health Canada updates Canadians on estimates of health risks for recalle... Posted 2018-09-11 |
| The United States: Updated: Torrent Pharmaceuticals Limited issues voluntary nat... Posted 2018-09-01 |
| The United States: Updated: Torrent Pharmaceuticals Limited issues voluntary nat... Posted 2018-08-22 |
| European Union: Update on medicines containing valsartan from Zhejiang Tianyu. C... Posted 2018-08-21 |
| Canada: Teva Canada expands recall of valsartan drugs to include additional lots... Posted 2018-08-20 |
| European Union: Update on review of valsartan medicines due to detection of NDMA... Posted 2018-08-11 |
| The United States: Camber Pharmaceuticals, Inc. issues voluntary nationwide reca... Posted 2018-08-10 |
| The United States: FDA updates on valsartan recalls Posted 2018-08-08 |
| Taiwan: Investigation of imported valsartan active pharmaceutical ingredient com... Posted 2018-08-06 |
| European Union: Update on review of recalled valsartan medicines. Preliminary as... Posted 2018-08-03 |
| Taiwan: Taiwan Food and Drug Administration’s full investigation on abnormal inc... Posted 2018-08-03 |
| Updates on the recall of valsartan-containing products (Letter to Healthcare Pro... Posted 2018-08-03 |
| The United States: FDA updates healthcare professionals and patients on recent v... Posted 2018-07-19 |
| European Union: Update on review of valsartan medicines following detection of i... Posted 2018-07-18 |
| The United States: FDA announces voluntary recall of several medicines containin... Posted 2018-07-14 |
| The United Kingdom：Class 1 Medicines Recall: Action Now – including out of hours... Posted 2018-07-11 |
| Taiwan: Taiwan Food and Drug Administration’s investigation of abnormal incident... Posted 2018-07-10 |
| Canada: Several drugs containing valsartan being recalled due to contamination w... Posted 2018-07-10 |
| Recall of five valsartan-containing products (Letter to Healthcare Professionals... Posted 2018-07-09 |
| Macau: Recall of 6 medicines Posted 2018-07-09 |
| European Union: EMA reviewing medicines containing valsartan from Zhejiang Huaha... Posted 2018-07-06 |
| The United Kingdom: Blood pressure and heart medication (valsartan) recalled fro... Posted 2018-07-06 |
| Recall of five valsartan-containing products (Letter to Healthcare Professiona... Posted 2018-07-06 |
